【Neuronetics Inc(STIM)投资者维权信息】
2021年10月12日Neuronetics Inc(STIM)公布了初步收入结果,预计第三季度的总收入约为 1380 万美元,而此前发布的指导为 1500 万美元至 1600 万美元。公司还下调了全年收入指引,预计 2021 财年在 5,330 万美元至 5,430 万美...查看全文
蹊之美股生物医药2021-08-04 23:10
作者:林出
微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
Arcturus Therapeutics (NASDAQ:ARCT) +68%
Flora Growth (NASDAQ:FLGC) +62%
Translate Bio (NASDAQ:TBIO) +29%
Outlook Therapeutics (NASDAQ:OTLK) +6%
Losers:
Neuronet...查看全文
$Neuronetics(STIM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001192482-20-000408 Size: 8 KB 网页链接
$Neuronetics(STIM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001192482-20-000406 Size: 4 KB 网页链接
$Neuronetics(STIM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001192482-20-000403 Size: 8 KB 网页链接
$Neuronetics(STIM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001192482-20-000401 Size: 4 KB 网页链接
$Neuronetics(STIM)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001192482-20-000399 Size: 6 KB 网页链接
$Neuronetics(STIM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001192482-20-000370 Size: 4 KB 网页链接
$Neuronetics(STIM)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-20-140432 Act: 34 Size: 29 KB 网页链接
$Neuronetics(STIM)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001564590-20-021268 Act: 34 Size: 7 MB 网页链接
$Neuronetics(STIM)$ 8-K Current report, item 7.01 Accession Number: 0001564590-20-021011 Act: 34 Size: 34 KB 网页链接
$Neuronetics(STIM)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001564590-20-020997 Act: 34 Size: 521 KB 网页链接